EYPT logo

EyePoint Pharmaceuticals (EYPT) Depreciation And Amortization

Annual D&A

$464.00 K
-$1.98 M-81.03%

December 31, 2023

Summary

Performance

1-Year Change

-81.03%

3-Year Change

-82.48%

5-Year Change

-65.01%

15-Year Change

-43.07%

EYPT Depreciation And Amortization Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

28.03%
EYPT annual depreciation & amortization is higher than 28.03% of companies in Healthcare sector

High & Low

All-time High

$8.72 M
EYPT annual depreciation & amortization is currently -94.68% below its historical high of $8.72 million

3-Year Low

$464.00 K
EYPT annual depreciation & amortization is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
EYPT previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 7, 2025
EYPT next annual earnings announcement is scheduled for Mar 7, 2025

Related metrics

Annual Total Expenses

$121.08 M
EYPT annual total expenses is $121.08 million

Annual Operating Expenses

$116.45 M
EYPT annual total operating expenses is $116.45 million

Annual Cost Of Goods Sold

$4.63 M
EYPT annual cost of goods sold is $4.63 million

Annual Interest Expense

$1.25 M
EYPT annual interest expense is $1.25 million

Quarterly D&A

$408.00 K
+$46.00 K+12.71%

September 30, 2024

Summary

Performance

3-Month Change

+12.71%

1-Year Change

+254.78%

3-Year Change

+21.79%

5-Year Change

+21.79%

EYPT Quarterly D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

46.94%
EYPT quarterly depreciation & amortization is higher than 46.94% of companies in Healthcare sector

High & Low

All-time High

$1.11 M
EYPT quarterly depreciation & amortization is currently -63.28% below its historical high of $1.11 million

3-Year Low

$105.00 K
EYPT quarterly depreciation & amortization is currently +288.57% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EYPT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
EYPT next earnings announcement is scheduled for Mar 7, 2025

Related metrics

Quarterly Total Expenses

$43.27 M
EYPT quarterly total expenses is $43.27 million

Quarterly Operating Expenses

$42.54 M
EYPT quarterly total operating expenses is $42.54 million

Quarterly Cost Of Goods Sold

$736.00 K
EYPT quarterly cost of goods sold is $736.00 thousand

Quarterly Interest Expense

$0.00
EYPT quarterly interest expense is $0.00

TTM D&A

$1.19 M
+$293.00 K+32.85%

September 30, 2024

Summary

Performance

3-Month Change

+32.85%

1-Year Change

+72.49%

3-Year Change

-51.55%

5-Year Change

-51.55%

EYPT TTM D&A Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

40.74%
EYPT TTM depreciation & amortization is higher than 40.74% of companies in Healthcare sector

High & Low

All-time High

$4.28 M
EYPT TTM depreciation & amortization is currently -72.33% below its historical high of $4.28 million

3-Year Low

$464.00 K
EYPT TTM depreciation & amortization is currently +155.39% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
EYPT previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 7, 2025
EYPT next earnings announcement is scheduled for Mar 7, 2025

Related metrics

Annual Total Expenses

$121.08 M
EYPT annual total expenses is $121.08 million

Annual Operating Expenses

$116.45 M
EYPT annual total operating expenses is $116.45 million

TTM Cost Of Goods Sold

$3.89 M
EYPT TTM cost of goods sold is $3.89 million

TTM Interest Expense

$0.00
EYPT TTM interest expense is $0.00

EYPT Depreciation And Amortization Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-81.0%+254.8%+72.5%
3 y3 years-82.5%+21.8%-51.5%
5 y5 years-65.0%+21.8%-51.5%

EYPT Depreciation And Amortization Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-83.3%at low-42.6%+288.6%-57.8%+155.4%
5 y5-year-83.3%at low-42.6%+288.6%-57.8%+155.4%
alltimeall time-94.7%+118.8%-63.3%+848.8%-72.3%+155.4%

EyePoint Pharmaceuticals Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sep 2024
-
$408.00 K(+12.7%)
$1.19 M(+32.8%)
Jun 2024
-
$362.00 K(+19.5%)
$892.00 K(+34.7%)
Mar 2024
-
$303.00 K(+170.5%)
$662.00 K(+42.7%)
Dec 2023
$464.00 K(-81.0%)
$112.00 K(-2.6%)
$464.00 K(-32.5%)
Sep 2023
-
$115.00 K(-12.9%)
$687.00 K(-46.5%)
Jun 2023
-
$132.00 K(+25.7%)
$1.28 M(-30.8%)
Mar 2023
-
$105.00 K(-68.7%)
$1.85 M(-24.2%)
Dec 2022
$2.45 M(-11.7%)
$335.00 K(-52.9%)
$2.45 M(-12.9%)
Sep 2022
-
$711.00 K(+1.0%)
$2.81 M(+0.4%)
Jun 2022
-
$704.00 K(+1.1%)
$2.80 M(+0.7%)
Mar 2022
-
$696.00 K(-0.3%)
$2.78 M(+0.3%)
Dec 2021
$2.77 M(+4.6%)
$698.00 K(-0.4%)
$2.77 M(+1.1%)
Sep 2021
-
$701.00 K(+2.3%)
$2.74 M(+1.4%)
Jun 2021
-
$685.00 K(-0.3%)
$2.70 M(+0.6%)
Mar 2021
-
$687.00 K(+2.7%)
$2.69 M(+1.5%)
Dec 2020
$2.65 M(+1.7%)
$669.00 K(+1.1%)
$2.65 M(+0.7%)
Sep 2020
-
$662.00 K(-1.2%)
$2.63 M(+0.6%)
Jun 2020
-
$670.00 K(+3.4%)
$2.61 M(+0.8%)
Mar 2020
-
$648.00 K(-0.3%)
$2.59 M(-0.4%)
Dec 2019
$2.60 M(+96.4%)
$650.00 K(+0.6%)
$2.60 M(+33.3%)
Sep 2019
-
$646.00 K(-0.5%)
$1.95 M(-0.6%)
Jun 2019
-
$649.00 K(-1.5%)
$1.97 M(-0.4%)
Mar 2019
-
$659.00 K(+0.2%)
$1.97 M(+24.5%)
Dec 2018
$1.33 M(+15.5%)
-
-
Sep 2018
-
$658.00 K(+0.3%)
$1.58 M(+38.1%)
Jun 2018
$1.15 M(+40.9%)
$656.00 K(+1425.6%)
$1.15 M(+62.6%)
Mar 2018
-
$43.00 K(-81.1%)
$706.00 K(-18.8%)
Dec 2017
-
$228.00 K(+3.2%)
$869.00 K(+2.6%)
Sep 2017
-
$221.00 K(+3.3%)
$847.00 K(+3.9%)
Jun 2017
$815.00 K(-10.2%)
$214.00 K(+3.9%)
$815.00 K(-4.3%)
Mar 2017
-
$206.00 K(0.0%)
$852.00 K(-1.2%)
Dec 2016
-
$206.00 K(+9.0%)
$862.00 K(-1.6%)
Sep 2016
-
$189.00 K(-24.7%)
$876.00 K(-3.5%)
Jun 2016
$908.00 K(+2.9%)
$251.00 K(+16.2%)
$908.00 K(+3.1%)
Mar 2016
-
$216.00 K(-1.8%)
$881.00 K(+0.5%)
Dec 2015
-
$220.00 K(-0.5%)
$877.00 K(+0.6%)
Sep 2015
-
$221.00 K(-1.3%)
$872.00 K(-1.1%)
DateAnnualQuarterlyTTM
Jun 2015
$882.00 K(-3.8%)
$224.00 K(+5.7%)
$882.00 K(-0.9%)
Mar 2015
-
$212.00 K(-1.4%)
$890.00 K(-2.1%)
Dec 2014
-
$215.00 K(-6.9%)
$909.00 K(-0.9%)
Sep 2014
-
$231.00 K(-0.4%)
$917.00 K(0.0%)
Jun 2014
$917.00 K(-7.7%)
$232.00 K(+0.4%)
$917.00 K(-1.7%)
Mar 2014
-
$231.00 K(+3.6%)
$933.00 K(-1.9%)
Dec 2013
-
$223.00 K(-3.5%)
$951.00 K(-2.7%)
Sep 2013
-
$231.00 K(-6.9%)
$977.00 K(-1.7%)
Jun 2013
$994.00 K(-55.4%)
$248.00 K(-0.4%)
$994.00 K(-2.3%)
Mar 2013
-
$249.00 K(0.0%)
$1.02 M(+1.3%)
Dec 2012
-
$249.00 K(+0.4%)
$1.00 M(-37.9%)
Sep 2012
-
$248.00 K(-8.5%)
$1.62 M(-27.3%)
Jun 2012
$2.23 M(-33.6%)
$271.00 K(+14.8%)
$2.23 M(-20.8%)
Mar 2012
-
$236.00 K(-72.7%)
$2.81 M(-17.8%)
Dec 2011
-
$863.00 K(+0.7%)
$3.42 M(+0.8%)
Sep 2011
-
$857.00 K(+0.2%)
$3.39 M(+1.1%)
Jun 2011
$3.35 M(+0.9%)
$855.00 K(+1.3%)
$3.35 M(+1.7%)
Mar 2011
-
$844.00 K(+1.1%)
$3.30 M(+0.6%)
Dec 2010
-
$835.00 K(+1.7%)
$3.28 M(-0.4%)
Sep 2010
-
$821.00 K(+2.6%)
$3.29 M(-1.0%)
Jun 2010
$3.33 M(-3.3%)
$800.00 K(-2.8%)
$3.33 M(-0.7%)
Mar 2010
-
$823.00 K(-3.1%)
$3.35 M(+0.8%)
Dec 2009
-
$849.00 K(-0.6%)
$3.32 M(-0.0%)
Sep 2009
-
$854.00 K(+3.6%)
$3.32 M(-3.3%)
Jun 2009
$3.44 M(-19.7%)
$824.00 K(+3.6%)
$3.44 M(-5.8%)
Mar 2009
-
$795.00 K(-6.5%)
$3.65 M(-6.0%)
Dec 2008
-
$850.00 K(-12.3%)
$3.88 M(-6.2%)
Sep 2008
-
$969.00 K(-6.6%)
$4.14 M(-3.3%)
Jun 2008
$4.28 M(-50.9%)
$1.04 M(+1.0%)
$4.28 M(+31.9%)
Mar 2008
-
$1.03 M(-7.3%)
$3.25 M(+46.3%)
Dec 2007
-
$1.11 M(-0.3%)
$2.22 M(+99.7%)
Sep 2007
-
$1.11 M
$1.11 M
Jun 2007
$8.72 M(+0.2%)
-
-
Jun 2006
$8.70 M(+70.2%)
-
-
Jun 2005
$5.11 M(+2022.0%)
-
-
Jun 2004
$240.90 K(+13.6%)
-
-
Jun 2003
$212.10 K
-
-

FAQ

  • What is EyePoint Pharmaceuticals annual depreciation & amortization?
  • What is the all time high annual D&A for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals annual D&A year-on-year change?
  • What is EyePoint Pharmaceuticals quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals quarterly D&A year-on-year change?
  • What is EyePoint Pharmaceuticals TTM depreciation & amortization?
  • What is the all time high TTM D&A for EyePoint Pharmaceuticals?
  • What is EyePoint Pharmaceuticals TTM D&A year-on-year change?

What is EyePoint Pharmaceuticals annual depreciation & amortization?

The current annual D&A of EYPT is $464.00 K

What is the all time high annual D&A for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high annual depreciation & amortization is $8.72 M

What is EyePoint Pharmaceuticals annual D&A year-on-year change?

Over the past year, EYPT annual depreciation & amortization has changed by -$1.98 M (-81.03%)

What is EyePoint Pharmaceuticals quarterly depreciation & amortization?

The current quarterly D&A of EYPT is $408.00 K

What is the all time high quarterly D&A for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high quarterly depreciation & amortization is $1.11 M

What is EyePoint Pharmaceuticals quarterly D&A year-on-year change?

Over the past year, EYPT quarterly depreciation & amortization has changed by +$293.00 K (+254.78%)

What is EyePoint Pharmaceuticals TTM depreciation & amortization?

The current TTM D&A of EYPT is $1.19 M

What is the all time high TTM D&A for EyePoint Pharmaceuticals?

EyePoint Pharmaceuticals all-time high TTM depreciation & amortization is $4.28 M

What is EyePoint Pharmaceuticals TTM D&A year-on-year change?

Over the past year, EYPT TTM depreciation & amortization has changed by +$498.00 K (+72.49%)